353 results on '"Ram-Wolff, Caroline"'
Search Results
2. Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
3. International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies
4. Graft-versus-lymphoma effect in skin after allogeneic hematopoietic stem cell transplantation for Sézary syndrome
5. Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
6. Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicenter retrospective study (Moga-stop study)
7. Real-world study on the use of pegylated interferon alpha-2a for treatment of mycosis fungoides/Sézary syndrome using Time to Next Treatment as a measure of clinical benefit: An EORTC CLTG study
8. Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients
9. Periorbital erythema and oedema revealing angioimmunoblastic T cell lymphoma
10. Real-world study of pegylated interferon α-2a to treat mycosis fungoides/Sézary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study.
11. Clinical characteristics of Mycosis fungoides palmaris et plantaris: two cases and a systematic literature review
12. Impact of blood tumour clone frequency on time to next treatment in mycosis fungoides
13. Targeting TGF-beta activation in cutaneous T-cell lymphomas
14. Sezary syndrome revealed by PD‐L1 blockade for tumor stage mycosis fungoides
15. CD39 is expressed by a wide range of cutaneous T‐cell lymphomas
16. CD30-positive anaplastic large-cell lymphoma associated with mycosis fungoides after treatment with dupilumab
17. Mogamulizumab-induced vitiligo in patients with Sézary syndrome: three cases
18. IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial
19. Syndrome de Sézary.
20. Skin involvement in systemic lymphoma of follicular helper T-cell origin: a cohort study of 57 patients
21. Primary cutaneous follicle center lymphoma with secondary systemic evolution
22. CD38 targeting in aggressive, treatment-refractory cutaneous T-cell lymphomas
23. Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
24. Efficacy and tolerability of mogamulizumab in patients with mycosis fungoides or Sézary syndrome: retrospective and real-world data from centres of the French Study Group of Cutaneous Lymphoma
25. International Study of SS Shows Superiority of Combination Therapy & Heterogeneity of Treatment Strategies
26. Severe relapses of cutaneous T‐cell lymphoma after treatment of chronic graft‐versus‐host disease with ruxolitinib
27. A Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg Type
28. Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas
29. Targeting TGF-β Activation in Cutaneous T-Cell Lymphomas
30. Exploring the non-lymphocytic cutaneous microenvironment in advanced cutaneous T-cell lymphomas using single-cell RNA-sequencing
31. Visceral leishmaniasis in patients with lymphoma: Case reports and review of the literature
32. Skin involvement in systemic lymphoma of follicular helper T‐cell origin: A cohort study of 57 patients.
33. Toxic epidermal necrolysis possibly associated with mogamulizumab in a patient with Sézary syndrome
34. CD38 targeting in aggressive, treatment-refractory cutaneous T-cell lymphomas
35. Severe relapses of cutaneous T‐cell lymphoma after treatment of chronic graft‐versus‐host disease with ruxolitinib.
36. P-205 - Toxic epidermal necrolysis possibly associated with mogamulizumab in a patient with Sézary syndrome
37. P-166 - Primary cutaneous follicle center lymphoma with secondary systemic evolution
38. O-150 - Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
39. O-146 - Efficacy and tolerability of mogamulizumab in patients with mycosis fungoides or Sézary syndrome: retrospective and real-world data from centres of the French Study Group of Cutaneous Lymphoma
40. O-129 - Skin involvement in systemic lymphoma of follicular helper T-cell origin: a cohort study of 57 patients
41. O-103 - CD38 targeting in aggressive, treatment-refractory cutaneous T-cell lymphomas
42. CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas
43. Primary cutaneous follicle centre lymphoma with secondary systemic evolution.
44. Clinical Features, Histological Characteristics, and Disease Outcomes of Mycosis Fungoides in Children and Adolescents: A Nationwide Multicentre Cohort of 46 Patients
45. Large-cell transformation is an independent poor prognostic factor in Sézary syndrome: analysis of 117 cases
46. Bone involvement in primary cutaneous diffuse large B-cell lymphoma, leg-type
47. 18F-fluorodeoxyglucose-positron emission tomography is more sensitive than computed tomography in initial staging of patients with an anaplastic T-cell lymphoma first presenting in the skin
48. Immediate hypersensitivity reaction to pegylated liposomal doxorubicin: management and outcome in four patients
49. Exploring the Nonlymphocytic Cutaneous Microenvironment in Advanced Cutaneous T-Cell Lymphomas using Single-Cell RNA Sequencing
50. Validation of AAC-11-Derived Peptide Anti-Tumor Activity in a Single Graft Sézary Patient-Derived Xenograft Mouse Model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.